First in Human: 7329 Clinical Trials, Page 30 of 733

« First Page «…5 10 15 …28 29 30 31 32 …35 40 45 … »Last Page »

Hide Studies Not Open or Pending

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Condition(s):Advanced Recurrent Malignant Pleural Epithelioid Mesothelioma; Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma; Advanced Recurrent Serous Ovarian Cancer; Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated)Last Updated:March 20, 2023Completed

A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants

Condition(s):Respiratory Syncytial Virus InfectionsLast Updated:April 21, 2021Completed

A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors

Condition(s):Advanced Solid TumorsLast Updated:October 27, 2022Recruiting

PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers

Condition(s):HPVLast Updated:January 18, 2023Not yet recruiting

First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy

Condition(s):Advanced Solid TumorLast Updated:September 9, 2019Completed

A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion

Condition(s):Primary Mitochondrial DiseasesLast Updated:August 31, 2021Not yet recruiting

A First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced Cancer

Condition(s):Advanced Solid TumorsLast Updated:April 18, 2023Recruiting

First-in-human Study of SAR443579 Infusion in Male and Female Participants of at Least 12 Years of Age With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL) or High Risk-myelodysplasia (HR-MDS)

Condition(s):Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic SyndromeLast Updated:May 3, 2023Recruiting

First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors

Condition(s):NeoplasmsLast Updated:May 3, 2012Completed

“First-in-human” Study To Assess the Safety and Tolerability of PBF-680 in Male Healthy Volunteers

Condition(s):AsthmaLast Updated:March 8, 2016Completed

« First Page «…5 10 15 …28 29 30 31 32 …35 40 45 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.